%0 Journal Article %A M. Prefontaine %A G. J. O'Connell %A E. Ryan %A K. J. Murphy %T Is there a role for CA-125 in monitoring patients with early endometrial cancer? %D 1991 %R 10.1046/j.1525-1438.1991.01040169.x %J International Journal of Gynecologic Cancer %P 169-172 %V 1 %N 4 %X Elevated CA-125 levels have been reported in some women with endometrial carcinoma. Current follow-up policy for these patients does not involve the use of tumor markers. CA-125 measurements were performed in 28 patients with a diagnosis of endometrial cancer, 14 clinically free of disease and 14 with known disease. Based on the sensitivity (0.64) and specificity (0.93) observed we constructed a model to estimate the predictive value of the assay as a marker in the follow-up of patients who have completed treatment. This model would involve a CA-125 assay every six months for five years in 100 patients with stage I and II disease. Despite the high statistical correlation between the clinical status of the patient and the CA-125 value observed in our study, the positive predictive value would be approximately 24% in such a follow-up protocol where a low prevalence of recurrent malignancy is expected. %U https://ijgc.bmj.com/content/ijgc/1/4/169.full.pdf